Cytokinetics (CYTK) PT Raised to $22 at Piper Sandler
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $71.40 +0.69%
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
Piper Sandler analyst Edward Tenthoff raised the price target on Cytokinetics (NASDAQ: CYTK) to $22.00 (from $20.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Truist Securities Reiterates Buy Rating on Cytokinetics (CYTK)
- Comstock Resources (CRK) PT Raised to $20 at Mizuho
- Cytokinetics aficamten shows cardiac benefits in two HCM trial analyses
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Edward TenthoffSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
